biocon biologics: revolutionizing healthcare with biosimilars
Published 1 year ago • 230 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
8:05
biocon-mylan’s biosimilar for cancer drug pegfilgrastim gets u.s. fda nod
-
3:02
biocon biologics' transformational milestones in 2022.
-
2:44
biocon biologics global scale capabilities
-
23:22
press meet: biocon biologics to acquire viatris' biosimilars business for global leadership
-
2:37
improving glioma surgery using a real time fluorescence biomarker
-
10:37
isatuximab, lenalidomide, bortezomib, and dex for newly-diagnosed multiple myeloma: gmmg-hd7
-
16:20
new insulin pumps coming this year & beyond (2024)
-
5:55
the biohackers making insulin 98% cheaper | just might work by freethink
-
11:18
biosimilar and interchangeable insulins: what clinicians need to know
-
5:12
cate lockhart discusses biosimilars such as semglee and the current standing of biosimilars, pbms
-
0:31
dexcom g7 is now integrated with beta bionics ilet bionic pancreas.
-
15:37
understanding biosimilar and interchangeable biosimilar insulins
-
0:41
how biosimilars can reduce healthcare costs
-
21:31
day 2 - virtual tour by biolinker
-
18:49
biosimilar insulins and interchangeability by dr. mangesh tiwaskar
-
1:10
highlights of #q3fy21
-
0:23
generic insulin designated
-
0:30
biosimilars are an alternative to expensive biologics: by the numbers
-
0:24
patients have an alternative to expensive biologic medicines: the facts
-
11:37
medtronic's new cgm powered by libre - explained
-
2:01
m'sia bioeconomy produces insulinn glargine products via biotechnology innovation
-
4:58
gan & lee pharmaceuticals - insulin biosimilars: meeting china's diabetes challenge